These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8009680)

  • 21. Nosocomial spread of RSV infection.
    Commun Dis Rep CDR Wkly; 1993 Jan; 3(2):5. PubMed ID: 7693189
    [No Abstract]   [Full Text] [Related]  

  • 22. The shedding and spreading of respiratory syncytial virus.
    Hall CB
    Pediatr Res; 1977 Mar; 11(3 Pt 2):236-9. PubMed ID: 846775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Respiratory syncytial virus prevention in infants at high risk of rehospitalization].
    Pinquier D
    Arch Pediatr; 2005 Nov; 12 Spec No 3():10-3. PubMed ID: 16422000
    [No Abstract]   [Full Text] [Related]  

  • 24. Reducing transmission of RSV.
    Paediatr Nurs; 2007 Feb; 19(1):12. PubMed ID: 17326550
    [No Abstract]   [Full Text] [Related]  

  • 25. Nosocomial respiratory syncytial virus infection in a pediatric ward.
    Vieira SE; Gilio AE; Miyao CR; Pahl MM; Lotufo JP; Hein N; Betta SL; Durigon EL; Botosso V; Ejzenberg B; Okay Y
    Infect Control Hosp Epidemiol; 2003 Jul; 24(7):468-9. PubMed ID: 12887231
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit.
    Abadesso C; Almeida HI; Virella D; Carreiro MH; Machado MC
    J Hosp Infect; 2004 Sep; 58(1):38-41. PubMed ID: 15350712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiological analysis of a nosocomial outbreak of respiratory syncytial virus associated pneumonia in a kangaroo mother care unit in South Africa.
    Visser A; Delport S; Venter M
    J Med Virol; 2008 Apr; 80(4):724-32. PubMed ID: 18297695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autumn fever.
    Owen OG
    Nurs Stand; 2000 Oct 18-24; 15(5):18-9. PubMed ID: 11971504
    [No Abstract]   [Full Text] [Related]  

  • 30. RSV: protecting the littlest patients.
    Lauts NM
    RN; 2005 Dec; 68(12):46-51; quiz 52. PubMed ID: 16411554
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of respiratory syncytial virus infection in a peripheral hospital: economic problems and ethical questions].
    Faverge B; Bonein M; Attou D; Benskhria S; Gratecos L
    Arch Pediatr; 2000 Apr; 7(4):429. PubMed ID: 10793937
    [No Abstract]   [Full Text] [Related]  

  • 32. Compliance of pediatric centers to Italian Society of Neonatology recommendations on prevention of respiratory syncytial virus infection: results of the second season of the Previeni Study.
    Macagno F;
    Pediatr Med Chir; 2005; 27(3-4):78-87. PubMed ID: 16910455
    [No Abstract]   [Full Text] [Related]  

  • 33. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
    Thorburn K
    Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nosocomial infections due to rotavirus and respiratory syncytial virus in pediatric wards: a 2-year study].
    Maille L; Beby-Defaux A; Bourgoin A; Koulmann L; Eucher V; Cardona J; Oriot D; Agius G
    Ann Biol Clin (Paris); 2000; 58(5):601-6. PubMed ID: 11022103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward.
    Mazzulli T; Peret TC; McGeer A; Cann D; MacDonald KS; Chua R; Erdman DD; Anderson LJ
    J Infect Dis; 1999 Nov; 180(5):1686-9. PubMed ID: 10515833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of nosocomial respiratory syncytial virus infections in an African setting.
    Madhi SA; Ismail K; O'Reilly C; Cutland C
    Trop Med Int Health; 2004 Apr; 9(4):491-8. PubMed ID: 15078268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis against respiratory syncytial virus in high-risk infants: administration of immune globulin and epidemiological surveillance of infection.
    Handal G; Logvinoff MM; Zegarra N; Allen L; Jesurun A; Levin G; Thida A
    Tex Med; 2000 May; 96(5):58-61. PubMed ID: 10843015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notes from the Field: Respiratory Syncytial Virus Infections in a Neonatal Intensive Care Unit - Louisiana, December 2017.
    Washington EJ; Rose EB; Langley GE; Hand JP; Benowitz I; Gerber SI; Salinas AL; Terry AL; Tonzel JL; Sokol TM; Smith AT; Richardson GJ
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(1):20-21. PubMed ID: 30629570
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of hospital-acquired respiratory viral infections: Assessment of a multimodal intervention program.
    Mermel LA; Jefferson JA; Smit MA; Auld DB
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):362-364. PubMed ID: 30767792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Main results of a national multicenter study assessing the compliance of pediatric centers to Italian Society of Neonatology recommendations on prevention of respiratory syncytial virus infection.
    Macagno F;
    Pediatr Med Chir; 2005; 27(3-4):70-7. PubMed ID: 16910454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.